Genetic and Molecular Abnormalities in Congenital Cystic Adenomatoid Malformations

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 11, 2012

Primary Completion Date

October 11, 2015

Study Completion Date

October 11, 2015

Conditions
Congenital Cystic Adenomatoid Malformation (CCAM)
Interventions
GENETIC

Patient

Blood and histological samples will be done at day of the inclusion.

Trial Locations (1)

75015

Necker-Enfants Malades Hospital, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01732185 - Genetic and Molecular Abnormalities in Congenital Cystic Adenomatoid Malformations | Biotech Hunter | Biotech Hunter